ACVR1 and neoplasm: Overall, our results suggest that a combination strategy to inhibit both the extracellular STIP1-ALK2 signaling and intracellular STIP1-HSP90 signaling would be ideal to thoroughly block STIP1-induced tumor growth in RCC bone metastasis.